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Pituitary Ablation for Diabetic Retinopathy* 
OLOF H. PEARSON 
Department of Medicine, Western Reserve University School of 
Medicine, Cleveland, Ohio 
Ablation of the p1tmtary gland 
appears to alter the course of dia-
betic retinopathy in some patients. 
This is purely an empirical form of 
therapy. It developed mostly from 
the observation in a patient with 
advanced diabetic retinopathy who, 
following pregnancy, hemorrhage, 
and the onset of Sheehan's syn-
drome (or hypopituitarism) , 
showed marked regression of the 
retinopathy. This observation was 
made by Poulsen (1953). Shortly 
thereafter, Luft, Olivecrona, and 
Sjogren, (1955) , in Stockholm, per-
formed surgical hypophysectomy in 
a group of patients with rather 
advanced diabetic vascular disease 
and diabetic retinopathy. The re-
sults were not very good on a long-
term basis, but did demonstrate 
that in some of these patients the 
course of the diabetic retinopathy 
apparently was altered favorably. It 
has now been confirmed by several 
workers that removal of the pitui-
tary gland can alter the course of 
the changes just described by Dr. 
Chan. 
* These studies have been carried 
out in collaboration with Drs. W. F. 
Collins, Jr., C. N. Shealy, C. I. 
Thomas, and B. Kaufman, and were 
supported by grants from the U. S. 
Public Health Service, CA 05197-06, 
FR 80-02, and the American Cancer 
Society, T 46 F. 
SURGICAL RISK OF 
HYPOPHYSECTOMY IN 
DIABETICS 
The idea for this therapeutic 
measure goes back to Houssay's 
observation that removal of the 
pituitary gland has an ameliorating 
effect on diabetes mellitus. There 
were a few early attempts to do 
hypophysectomies before these 
more recent observations, but they 
were probably premature because 
the replacement hormones neces-
sary to maintain the hypophysec-
tomized patient were not available 
and these patients all succumbed 
quickly. It also became very ap-
parent that in carrying out surgical 
hyp ophysectomy in diabetic pa-
tients, there was a major threat to 
life. Of the first 20 patients op-
erated on by Dr. Olivecrona 
(1955), about a third died in the 
immediate post-operative period. In 
other clinics, Dr. Bronson Ray be-
gan to do hypophysectomies about 
1955. In his first 14 patients, there 
were two operative deaths. Dr. Wil-
liam Collins and I started our ex-
perience with the procedure about 
1960 in Cleveland, and in a group 
of eight patients, we had one op-
erative death. So it became ap-
parent that although surgical hy-
pophysectomy can be performed in 
other types of patients with very 
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little mortality and morbidity, the 
problem was quite different in the 
diabetic patient. Those patients of 
Dr. Luft (1962) who survived had 
convulsions and periods of stupor 
in the post-operative period. It be-
came apparent therefore that the 
brain behaved quite differently in 
the diabetic patient. It was obvious 
that there must be a more subtle 
way of changing the hormonal en-
vironment of these patients. 
BENEFICIAL EFFECT OF 
HYPOPHYSECTOMY; RELATION 
TO GROWTH HORMONE 
Many studies have been carried 
out to try to determine by what 
mechanism hypophysectomy could 
alter the course of this disease. I 
think we can say emphatically that 
we still have no inkling. It is ap-
parent that hypophysectomy does 
ameliorate the metabolic defect in 
the diabetic patient, in that there is 
a marked reduction in insulin re-
quirement. In the juvenile diabetic, 
the dose of insulin drops to about 
a third of its previous level. Adult 
diabetics frequently do not require 
insulin after hypophysectomy. The 
amelioration of the diabetic defect 
may be due to withdrawal of 
growth hormone, since administra-
tion of human growth hormone to 
diabetics produces a marked exacer-
bation of the diabetic state. 
More recently the ability to meas-
ure growth hormone in the serum 
of patients has permitted an evalu-
ation of whether the hormone levels 
are normal or abnormal in the 
diabetic patient. Preliminary stud-
ies seem to indicate that blood 
growth hormone levels are per-
fectly normal in diabetics, in-
cluding those who have diabetic 
retinopathy. With insulin-induced 
hypoglycemia, growth hormone 
levels rise very much as they do in 
normal subjects. So, a superficial 
look at growth hormone in these 
patients would seem to indicate that 
there is no basic abnormality such 
as is seen in acromegaly and in the 
diabetes that may be associated 
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with acromegaly. However, I think 
further data are needed because 
although diabetic patients may have 
normal growth hormone levels, 
these levels may be too high in rela-
tion to the elevated blood sugar. 
There may be fluctuations of growth 
hormone levels during the period of 
the day which may be quite ab-
normal in the diabetic patient as 
compared with the non-diabetic. 
But this information has not helped 
us really. The incidence of diabetic 
retinopathy in acromegalic patients 
does not seem to be any higher 
than, and certainly not as high as, 
in patients with ordinary diabetes 
mellitus, although definite micro-
angiopathy has been seen in acro-
megalic patients and particularly in 
those who have a diabetic tendency. 
EXPERIENCE WITH 
HYPOPHYSECTOMY BY 
YTTRIUM90 IMPLANTS 
To study further the clinical re-
sponse of patients to hypophy-
sectomy, it seemed worthwhile to 
try another approach to ablation of 
the pituitary gland. Dr. Forrest and 
co-workers (1959) in Scotland has 
been working on the implantation 
of radioactive materials into the 
pituitary via a trans-nasal, trans-
sphenoidal approach. The early re-
sults were not very satisfactory but 
about five or six years ago, he 
adopted a technique in which he 
introduced two yttrium rods at-
tached to a stainless steel screw into 
each side of the pituitary gland. 
The stainless steel screw was de-
signed to do two things; first , it 
would fix the yttrium rod which 
would deliver a necrotizing dose of 
radiation to the pituitary, so that 
the accuracy of placement of the 
rod could be enhanced, and, it 
would plug the hole that was used 
to put the yttrium90 into the pitui-
tary, thus preventing such compli-
cations as rhinorrhea and menin-
gitis. 
Dr. Collins and I embarked on 
this program about three years ago 
and we have now had experience 
with this type of implantation in 
125 patients. Specifically we have 
had experience with 32 patients 
with diabetic retinopathy. We have 
not been able to confirm Forrest's 
observations ( 1959) that this tech-
nique is without complications. We 
have had rhinorrhea in three pa-
tients, and meningitis in two; all of 
these subsided, however, without 
residual damage. From a surgical 
point of view, the procedure is in-
deed a benign one and is useable in 
patients who are completely un-
suitable for surgical hypophysec-
tomy. We have had no mortality 
in the original procedure in these 
32 patients, but we did have one 
surgical mortality in a patient who 
was re-operated on a year later. 
We have seen no significant nerve 
palsies. 
EFFECT ON VISION AND 
RETINOPATHY 
In this group we have studied 
patients with quite advanced dia-
betic retinopathy. In two thirds of 
the patients, we have seen signifi-
cant improvement in terms of bet-
ter vision. The most striking change 
that the ophthalmologist reports is a 
decrease in edema of the retina, a 
decrease in hemorrhages, in the 
neovascularization, and in micro-
aneurysms. The retinitis proliferans 
shows no change. The fibrous 
changes remain, but the vascularity 
of this proliferative disease can re-
gress. I specifically state that there 
is a decrease in these changes and 
not a complete disappearance of 
all of these vascular difficulties. But 
the clinical response in these pa-
tients has indeed been quite re-
markable. 
Of the group whom we con-
sidered to be failures, there were 
only three who have shown pro-
gressive changes in terms of hemor-
rhage going on to destroy vision. 
In two of these three, we felt that 
the hypophysectomy had been in-
complete and that one of these had 
shown transient improvement, fol-
lowed by a recurrence of hemor-
rhages which went on to destroy 
vision. Whether complete hypophy-
sectomy is essential for the best 
results is of course not certain. But 
some of the data that we have sug-
gests that the more complete the 
hypophysectomy, the better the re-
sults. 
Also in the group that we con-
sidered to be failures were patients 
who had bilateral retinitis pro-
liferans with large areas of fibrous 
tissue covering the disc and extend-
ing toward the macular area. A 
number of these patients had only 
peripheral vision. Visual acuity was 
less than 20/ 200 and yet we rea-
soned that if we could retain this 
degree of peripheral vision, the 
hypophysectomy would have been 
worthwhile. In five such patients 
we have seen no significant change 
except for some decrease in the 
vascularity of the diabetic retinopa-
thy. But there has been no improve-
ment in vision and these patients 
cannot be considered successes. It 
is striking, however, that a number 
of patients with retinitis proliferans 
with sparing of the macula and use-
ful vision, seem to have shown no 
progression of the scarring. We 
have patients who have gone as 
long as nine years now without 
evidence of progression of the 
retinopathy. 
SUMMARY 
Our clinical experience and the 
experience of others seems to indi-
cate that pituitary ablation can in-
duce a significant beneficial effect 
on the course of diabetic retinitis, 
even in advanced stages. We have 
no strict criteria for the selection 
of patients. When surgical hypophy-
sectomy is being done, the major 
restriction is whether the patient 
has a fair chance of getting through 
the procedure without great risk of 
death or serious complication. With 
yttrium-implant hypophysectomy, 
the risk of death from the pro-
cedure itself has been practically 
eliminated. The morbidity would 
be much less if the rhinorrhea and 
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the threat of meningitis could be 
eliminated completely. From our 
experience, the procedure appears 
to be futile in patients with severe 
retinitis proliferans with very little 
vision left. Where there is useful 
vision left, even 20/ 100 or less in 
one eye, where there appears to be 
a chance of reversibility, we have 
seen striking improvement lasting 
for several years. 
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